Arbutus Biopharma Corp - COM (ABUS)

Historical Portfolio Holders from Q2 2015 to Q1 2024

All holders as of March 31, 2024: Q1 2024
Type / Class: Equity / COM
Shares, excl. options Q1 2024: 73.8 M
Holdings value Q1 2024: $191 M
Value change Q1 2024: +$6.78 M
Grand Portfolio weight change Q1 2024: +0%
Number of holders: 112
Number of buys Q1 2024: 49
Number of sells Q1 2024: -45
Average buys Q1 2024 %: +0.003%
Average sells Q1 2024 %: 0%
CUSIP: 03879J100

Reported Shares, Excluding Options vs Price

Reported Value, Excluding Options

Total Investors

Period	Shares, Excl. Options	Value, Excl. Options	Change	Puts Notional Value	Calls Notional Value	Price	Investors
2024 Q1	73.8 M	$191 M	+$6.78 M	1.41 M	12.4 M	$2.58	112
2023 Q4	71.3 M	$178 M	+$6.61 M	3.27 M	3.57 M	$2.50	102
2023 Q3	70.5 M	$143 M	+$8.05 M	1.04 M	1.16 M	$2.03	92
2023 Q2	66 M	$152 M	+$7.4 M	1.02 M	1.48 M	$2.30	106
2023 Q1	61.8 M	$187 M	+$26.5 M	1.11 M	3.85 M	$3.03	115
2022 Q4	51.6 M	$120 M	+$17.7 M	1.64 M	2.87 M	$2.33	104
2022 Q3	46 M	$87.8 M	+$2.67 M	1.16 M	1.15 M	$1.91	112
2022 Q2	43.5 M	$118 M	+$1.78 M	2.17 M	2.66 M	$2.71	94
2022 Q1	42.4 M	$126 M	+$4.15 M	5.32 M	3.93 M	$2.98	103
2021 Q4	38.9 M	$151 M	+$14.6 M	6.71 M	9.54 M	$3.89	110
2021 Q3	34.6 M	$149 M	+$25.4 M	5.86 M	12.5 M	$4.29	94
2021 Q2	28.4 M	$86.1 M	+$8.19 M	3.17 M	2.17 M	$3.03	79
2021 Q1	25.4 M	$84.7 M	+$11.9 M	2.97 M	1.38 M	$3.33	84
2020 Q4	21.4 M	$75.9 M	-$4.92 M	5.47 M	3.89 M	$3.55	68
2020 Q3	21.4 M	$67 M	+$7.51 M	1.38 M	919 K	$3.13	54
2020 Q2	21.8 M	$39.7 M	+$964 K	0	99 K	$1.82	44
2020 Q1	17.5 M	$17.7 M	-$13.5 M	1 K	86 K	$1.01	36
2019 Q4	23.1 M	$64.2 M	+$11.8 M		244 K	$2.78	45
2019 Q3	17.6 M	$26.9 M	-$3.35 M	0	0	$1.53	40
2019 Q2	21.1 M	$44 M	-$10.5 M	38 K	23 K	$2.08	52
2019 Q1	24.1 M	$86.1 M	-$442 K	0	409 K	$3.58	62
2018 Q4	24.1 M	$92.4 M	-$11.1 M	312 K	383 K	$3.83	63
2018 Q3	24 M	$227 M	+$17.7 M	132 K	884 K	$9.45	84
2018 Q2	20.4 M	$149 M	+$30.1 M	699 K	1.83 M	$7.30	64
2018 Q1	18.4 M	$91.9 M	-$79.6 M	675 K	919 K	$5.00	44
2017 Q4	34.2 M	$173 M	+$4.99 M	5 K	80 K	$5.05	47
2017 Q3	31.1 M	$193 M	-$1.1 M	63 K	116 K	$6.20	47
2017 Q2	36.9 M	$133 M	+$3.19 M	99 K	0	$3.60	42
2017 Q1	31 M	$101 M	+$962 K	95 K	4 K	$3.25	45
2016 Q4	35.9 M	$88.1 M	+$3.85 M	816 K	97 K	$2.45	50
2016 Q3	33.4 M	$115 M	+$54.7 M	618 K	175 K	$3.44	46
2016 Q2	17.4 M	$60.4 M	-$710 K	438 K	189 K	$3.48	45
2016 Q1	17.5 M	$72.4 M	-$3.36 M	280 K	204 K	$4.13	45
2015 Q4	18.4 M	$81.7 M	-$100 M	82 K	237 K	$4.45	47
2015 Q3	34.9 M	$212 M	+$211 M	283 K	423 K	$6.09	51
2015 Q2	207 K	$2.46 M	+$2.46 M			$11.86	1